苯乙基异硫氰酸酯对良性前列腺上皮细胞增殖凋亡的影响及相关机制研究

doi:10.3969/j.issn.1006-7795.2021.06.010

摘要/Abstract

摘要： 目的探讨苯乙基异硫氰酸酯(phenethyl isothiocyanate,PEITC)对人类良性前列腺上皮细胞(benign prostatic hyperplasia cell line,BPH-1)增殖与凋亡的影响及其相关机制。方法体外培养人永生化前列腺上皮细胞,给予6、12、24 μmol/L PEITC或等量溶剂二甲基亚砜,分别作用6、12、24 h。采用CCK-8检测前列腺上皮细胞活性; Annexin V及PI标记,流式细胞技术检测PEITC处理24 h后 BPH-1细胞凋亡及坏死比例;Western blotting测定PEITC处理24 h后BPH-1细胞中X染色体连锁的凋亡抑制蛋白(X-linked inhibitor of apoptosis,XIAP)及自噬相关蛋白5-12 (Atg5-12)表达变化;RT-PCR检测PEITC处理24 h后BPH-1细胞中XIAP mRNA表达情况。结果 1) BPH-1细胞经过6、12、24 μmol/L PEITC处理6 h后,细胞相对活性分别为71.22%、48.90%、13.57%;处理12 h后分别为52.57%、42.37%、10.11%;处理24 h后分别为36.73%、25.88%、8.39%;处理36 h后分别为33.57%、25.83%、13.06%,呈现浓度依赖性和时间依赖性。2) BPH-1细胞在 6、12、24 μmol/L PEITC 处理24 h后,细胞凋亡率分别为19.5%、30.4%、40.1%;与对照组相比,12、24 μmol/L处理组差异均具有统计学意义(P<0.05)。 3) BPH-1 细胞在6、12、24 μmol/L PEITC处理24 h后,XIAP 蛋白表达量及 mRNA 表达量均下调,Atg5-12蛋白表达量下调,并呈现剂量依赖性。结论 PEITC可抑制前列腺上皮细胞增殖,通过下调BPH-1中XIAP mRNA而降低XIAP蛋白表达,促进前列腺上皮细胞的凋亡并呈现出剂量依赖性;同时PEITC下调了自噬相关蛋白Atg5-12;PEITC对凋亡与自噬的调节可能存在相关性。

关键词: 苯乙基异硫氰酸酯, 增殖, 凋亡, 自噬, X染色体连锁凋亡抑制蛋白, Atg5-12

Abstract: Objective To investigate the effects of phenethyl isothiocyanate (PEITC) on human benign prostatic epithelial cells(BPH-1). Methods Exposure of BPH-1 cells to PEITC at different concentrations (6, 12, and 24 μmol/L) for 6, 12, 24, or 36 hours. The suppression of cell proliferation was assessed with CCK-8 assay. The cell apoptosis was evaluated with Annexin V/PI staining by fluorescent flow-cytometric assay. The Western blotting analysis was applied to examine the expression of X-linked inhibitor-of-apoptosis protein (XIAP) and Atg5-12. The expression of XIAP mRNA was detected with RT-PCR. Results 1)Upon the treatment of PEITC at 6, 12, and 24 μmol/L, the cell relative viability was 71.22%, 48.90%, and 13.57%, respectively, for 6 hours; 52.57%, 42.37%, and 10.11%, respectively, for 12 hours; 36.73%, 25.88%, and 8.39% for 24 hours, respectively, and 33.57%, 25.83%, and 13.06%, respectively, for 36 hours. PEITC suppressed the proliferation of BPH-1 cells in a concentration-dependent way, compared with the control group (P<0.05). 2)The total percentages of apoptotic cells was 19.5%, 30.4%, and 40.1% in BPH-1 cells upon the treatment of PEITC at 6, 12, and 24 μmol/L for 24 hours, respectively. PEITC promoted cell apoptosis at concentrations of 12 μmol/L and 24 μmol/L, compared with the control group (P<0.05). 3)The relative expression of XIAP mRNA and XIAP was suppressed in a concentration-dependent way (6, 12, and 24 μmol/L) upon the treatment of PEITC for 24 hours. The expression of Atg 5-12 protein was also inhibited in a concentration-dependent way (6, 12, and 24 μmol/L) upon the treatment of PEITC for 24 hours. Conclusions PEITC suppressed the proliferation of benign prostatic epithelial cells and induced cell apoptosis by inhibiting the expression of XIAP mRNA and XIAP in a concentration-dependent way, which was probably associated with the suppressed autophagy pathway in BPH-1 cells.

Key words: phenethyl isothiocyanate(PEITC), proliferation, apoptosis, autophagy, X-linked inhibitor of apoptosis(XIAP), Atg5-12

中图分类号:

R697⁺.3

刘志斌, 靳松, 牛亦农. 苯乙基异硫氰酸酯对良性前列腺上皮细胞增殖凋亡的影响及相关机制研究[J]. 首都医科大学学报, 2021, 42(6): 961-966.

Liu Zhibin, Jin Song, Niu Yinong. The effects and mechanism of phenylethyl isothiocyanate on cell proliferation and apoptosis in BPH-1 cells[J]. Journal of Capital Medical University, 2021, 42(6): 961-966.

参考文献

[1] Roehrborn C G. Pathology of benign prostatic hyperplasia[J]. Int J Impot Res, 2008,20(Suppl 3): S11-18.
[2] Lim K B. Epidemiology of clinical benign prostatic hyperplasia[J]. Asian J Urol, 2017,4(3):148-151.
[3] Egan K B. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates[J]. Urol Clin North Am, 2016,43(3): 289-297.
[4] Strand D W, Costa D N, Francis F, et al. Targeting phenotypic heterogeneity in benign prostatic hyperplasia[J]. Differentiation,2017, 96:49-61.
[5] Gupta P, Wright S E, Kim S H, et al. Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms[J]. Biochim Biophys Acta, 2014, 1846(2):405-424.
[6] Upadhyaya B, Liu Y, Dey M. Phenethyl isothiocyanate exposure promotes oxidative stress and suppresses Sp1 transcription factor in cancer stem cells[J]. Int J Mol Sci, 2019, 20(5):1027.
[7] Beklemisheva A A, Feng J, Yeh Y A, et al. Modulating testosterone stimulated prostate growth by phenethyl isothiocyanate via Sp1 and androgen receptor down-regulation[J]. Prostate, 2007,67(8): 863-870.
[8] Liu T S, Chen C, Zhou B, et al. Isobaric tags for relative and absolute quantitation-based quantitative proteomic analysis of X-linked inhibitor of apoptosis and H2AX in etoposide-induced renal cell carcinoma apoptosis[J]. Chin Med J, 2019, 132(24):2941-2949.
[9] Pagano E, Laudato M,Griffo M,et al. Phytotherapy of benign prostatic hyperplasia. A minireview[J]. Phytother Res, 2014, 28(7):949-955.
[10] Lepor H . Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia[J]. Rev Urol, 2004, 6(Suppl 9):S3-S10.
[11] Yan J F, Xie Y, Si J, et al. Crosstalk of the caspase family and mammalian target of rapamycin signaling[J]. Int J Mol Sci, 2021, 22(2):817.
[12] Ayachi O, Barlin M, Broxtermann P N, et al. The X-linked inhibitor of apoptosis protein (XIAP) is involved in melanoma invasion by regulating cell migration and survival[J]. Cell Oncol, 2019,42(3):319-329.
[13] Park H H . Structural features of caspase-activating complexes[J]. Int J Mol Sci, 2012, 13(4):4807-4818.
[14] Hosseini E S, Nikkhah M, Hamidieh A A, et al. The lumiptosome, an engineered luminescent form of the apoptosome can report cell death by using the same Apaf-1 dependent pathway[J]. J Cell Sci, 2020, 133(10):jcs242636.
[15] Al-Qubaisi M S, Rasedee A, Flaifel M H, et al. Induction of apoptosis in cancer cells by NiZn ferrite nanoparticles through mitochondrial cytochrome C release[J]. Int J Nanomedicine, 2013,8(1): 4115-4130.
[16] Sakao K, Desineni S, Hahm E R, et al. Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo[J]. Prostate, 2012, 72(10):1104-1116.
[17] Klionsky D J, Emr S D. Autophagy as a regulated pathway of cellular degradation[J]. Science, 2000, 290(5497): 1717-1721.
[18] Romanov J, Walczak M, Ibiricu I, et al. Mechanism and functions of membrane binding by the Atg5–Atg12/Atg16 complex during autophagosome formation[J]. EMBO J, 2012,31(22): 4304-4317.
[19] Arakawa S, Honda S, Yamaguchi H, et al. Molecular mechanisms and physiological roles of Atg5/Atg7-independent alternative autophagy[J]. Proc Jpn Acad Ser B Phys Biol Sci, 2017, 93(6):378-385.
[20] Karow M, Fischer S, Mebling S, et al. Functional characterisation of the autophagy ATG12~5/16 complex in dictyostelium discoideum[J]. Cells, 2020, 9(5):1179.
[21] Pyo J O, Yoo S M, Ahn H H, et al. Overexpression of Atg5 in mice activates autophagy and extends lifespan[J]. Nat Commun, 2013, 4:2300.
[22] Bommareddy A, Hahm E R, Xiao D, et al. Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells[J]. Cancer Res, 2009, 69(8):3704-3712.
[23] Amaravadi R K, Yu D, Lum J J, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma[J]. J Clin Invest, 2007, 117(2):326-336.
[24] Xiong X X, Wu M B, Zhang H Y, et al. Atg5 siRNA inhibits autophagy and enhances norcantharidin induced apoptosis in hepatocellular carcinoma[J]. Int J Oncol,2015,47(4):1321-1328.